Blog
RSS FeedPosted by Michael Wonder on 20 Dec 2018
Decisions relating to the funded brands of some anti-retroviral treatments for HIV
20 December 2018 - PHARMAC is pleased to announce decisions to award sole supply for seven anti-retroviral treatments used in ...
Posted by Michael Wonder on 19 Dec 2018
'Jubilant' over drug funding
19 December 2018 - Dunedin hepatitis C campaigner Hazel Heal has received an early Christmas present: news Government drug-buying agency ...
Posted by Michael Wonder on 19 Dec 2018
Women who petitioned Parliament get nothing from PHARMAC
19 December 2018 - Women who petitioned Parliament get nothing from PHARMAC’s Santa ...
Posted by Michael Wonder on 18 Dec 2018
Proposal to amend the distribution and access criteria for dasatinib (Sprycel)
18 December 2018 - PHARMAC is seeking feedback on a proposal to amend the distribution arrangements and access criteria for ...
Posted by Michael Wonder on 17 Dec 2018
PHARMAC funding decision gives Kiwis with hepatitis C access to a potential cure
17 December 2018 - Life changing treatment for New Zealanders living with hepatitis C will be available from 1 February ...
Posted by Michael Wonder on 17 Dec 2018
Decision to fund a new hepatitis C treatment (Maviret) and to widen access to adalimumab (Humira) for psoriasis
17 December 2018 - PHARMAC is pleased to announce a decision to fund a new treatment for chronic hepatitis C ...
Posted by Michael Wonder on 14 Dec 2018
Decision in relation to infliximab, tocilizumab and rituximab
14 December 2018 - PHARMAC is pleased to announce a decision on how three hospital medicines (infliximab, tocilizumab and rituximab) ...
Posted by Michael Wonder on 13 Dec 2018
Frustrated at cancer treatment inequity
13 December 2018 - As appointed ambassador for the Lung Foundation NZ, I feel very frustrated the Government will not ...
Posted by Michael Wonder on 12 Dec 2018
Health organisations join calls for a review into government drug buying agency
12 December 2018 - Pressure is mounting on the government to announce a review into its drug buying agency with ...
Posted by Michael Wonder on 11 Dec 2018
Decision to list a new brand of iron polymaltose (Ferrosig)
11 December 2018 - PHARMAC is pleased to announce a decision to list a new brand of iron polymaltose inj ...
Posted by Michael Wonder on 10 Dec 2018
Breast cancer sufferer fighting for life-extending drugs wants PHARMAC inquiry
10 December 2018 - A woman fighting stage 4 breast cancer is a "little shy" of the $77,000 she needs ...
Posted by Michael Wonder on 10 Dec 2018
Proposal to open access to atomoxetine and change funded brand
10 December 2018 - PHARMAC is proposing to remove all funding restrictions from all presentations of atomoxetine, and change the ...
Posted by Michael Wonder on 07 Dec 2018
Proposal to list a new presentation of raltegravir and amend arrangements for raltegravir and posaconazole
7 December 2018 - PHARMAC is seeking feedback on a multi-product proposal with Merck Sharpe & Dohme. ...
Posted by Michael Wonder on 06 Dec 2018
Trapped abroad: NZ a 'death sentence' if she comes home
6 December 2018 - Rachel Paine never meant to settle overseas but coming home risks death. ...
Posted by Michael Wonder on 05 Dec 2018
PHARMAC - 2018 in review (update)
6 December 2018 - Further analysis of the ten new patent protected medicines (i.e. new chemical entities) listed in the ...